Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US 2020-06-24 12:10
Kangpu to Present Two Posters at the 2020 American Association for Cancer Research (AACR) Annual Meeting 2020-06-17 21:00
Immunexpress Awarded BARDA Contract to Develop SeptiCyte® RAPID for COVID-19 Patient Triage 2020-06-16 20:00
Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat® Research 2020-06-15 20:00
I-Mab and ABL Bio to Present Preclinical Data for Joint Bispecific Antibody Program at the 2020 American Association for Cancer Research Virtual Meeting II 2020-06-12 20:00
PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I 2020-06-11 00:00
Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody 2020-06-10 08:40
Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer 2020-06-09 10:10
Healios Successfully Establishes Proprietary Universal Donor Cell Research Line 2020-06-05 13:00
China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering 2020-06-04 04:00
Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE™ for the Treatment of Neuroblastoma 2020-06-03 21:08
New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis 2020-06-03 14:30
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma 2020-06-01 07:30
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type) 2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma 2020-06-01 07:30
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies 2020-05-31 20:00
Gracell Announces Two Presentations at the Annual Meeting of American Society of Clinical Oncology (ASCO) 2020-05-29 20:00
I-Mab Announces Upcoming Participation at June Conferences 2020-05-29 20:00
I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome 2020-05-28 04:05
Transcenta Presents First Data from Phase 1 Study of pH-Dependent PDL1 Antibody MSB2311 in Patients with Pre-treated Advanced Solid Tumors and Select Hematological Malignancies 2020-05-27 23:00
1 124 125 126 127 128 170